AwardedAwarded 21 November 2025
NHS National Framework for Generics Housekeeping
NHS England · NHS and health
In brief
NHS England awarded medical supplies work to Accord-UK Ltd, Teva UK Limited and Zentiva Pharma UK Ltd and 40 others on 21 November 2025.
It is split into 2 lots, so a supplier can bid for part of the work.
Built from the notice's own fields. Always check the official notice before you bid.
What the notice says
NHS National Framework for Generics Housekeeping
Offer reference number: CM/PHG/25/5733
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
CM/PHG/25/5733/01 Oral products
CESW/LSNE/NWLN 01/02/2026 to 31/05/2027 (16 months)
CM/PHG/25/5733/02 Hospital only products
DCE/DSW 01/02/2026 to 30/09/2027 (20 months)
DLS/DNE: 01/02/2026 to 31/01/2027 (12 months)
DLN/DNW 01/02/2026 to 31/01/2027 (12 months)
Lots
| Lot | Trade | Value |
|---|---|---|
| Lot 1 | — | — |
| Lot 2 | — | — |
Who won
| Winner | Lot | Value | Dates |
|---|---|---|---|
| Accord-UK Ltd Teva UK Limited (SME) Zentiva Pharma UK Ltd (SME) Thornton & Ross Limited Milpharm Limited Pfizer Limited Crescent Pharma Limited Day Lewis Medical Ltd Morningside Pharmaceuticals Ltd (SME) Brown and Burk UK Ltd (SME) Macarthys Laboratories Limited Mercury Pharmaceuticals Ltd (SME) Chiesi Ltd Infectopharm Ltd Rosemont Pharmaceuticals Ltd (SME) Drugsrus Ltd (SME) Kent Pharmaceuticals Ltd (SME) Alissa Healthcare Research Limited (SME) Luye Pharma Ltd (SME) Medreich PLC (SME) Relonchem Ltd 31 bids received | Lot 1 | £17,843,324 | Awarded 10 November 2025 1 February 2026 to 31 May 2027 |
| Novartis Pharmaceuticals UK Limited Baxter Healthcare Ltd (SME) Accord-UK Ltd Teva UK Limited (SME) Zentiva Pharma UK Ltd (SME) DR Reddy's Laboratories (UK) Limited Cipla (Eu) Limited Milpharm Limited Pfizer Limited Viatris UK Healthcare Ltd (SME) Amarox Limited (SME) Wockhardt UK Limited (SME) Hikma Pharmaceuticals International Ltd (SME) Macarthys Laboratories Limited Sun Pharma UK Limited (SME) Mercury Pharmaceuticals Ltd (SME) Kent Pharma UK Ltd (SME) Macarthys Laboratories Ltd T/A Martindale Pharma Mercury Pharmaceuticals Lt Novumgen Limited (SME) Tillomed Laboratories Limited (SME) Drugsrus Ltd (SME) Grindeks Kalceks UK Ltd (SME) Hameln Pharmaceuticals Ltd (SME) Kent Pharmaceuticals Ltd (SME) RPH Pharmaceuticals AB (SME) Zydus Pharmaceuticals UK Ltd (SME) Biocon JCSH Pharma Ltd (SME) Necessity Supplies Limited (SME) Seacross Pharmaceuticals Ltd (SME) 40 bids received | Lot 2 | £21,562,716 | Awarded 10 November 2025 1 February 2026 to 30 September 2027 |
Values as the award notice gives them, excluding VAT where stated.
Timeline
- Contract award notice · UK6, notice 072699-2025
- Contract details notice · UK7, notice 085542-2025
Last time this was bought
NHS National Framework Agreement for Omalizumab
- Won by
- Novartis Pharmaceuticals UK Limited, Celltrion Healthcare United Kingdom Limited, Mercury Pharmaceuticals Lt
- Awarded
- 12 December 2025
- Value
- £87,433,000
- Contract ends
- 31 August 2027
Matched on NHS England, the type of work and the title; it may be a related contract rather than the same one. Check the notice to be sure.
About the buyer
NHS EnglandLast 12 months
Procurements
1187Awards
476Suppliers it has used most for medical supplies
- Accord-UK Ltd11 contracts
- Teva UK Limited10 contracts
- Zentiva Pharma UK Ltd10 contracts
- Milpharm Limited8 contracts
- Thornton & Ross Limited8 contracts
Similar open tenders
All open medical supplies tenders- £85mestimated
- £3.6mestimated
- £250kestimated
- Value not stated
- £700kestimated
From notice 072699-2025 on Find a Tender, first published 11 November 2025, last updated 22 December 2025. We last checked for changes on 28 September 2026.